Vantage | May 2024

Vertex Portfolio News

Here are the latest updates on our portfolio companies across the Vertex network. Stay connected by signing up for our monthly newsletter here.

• Ansonic (China) raised a RMB100M Series C round
• Carv (China) raises USD10M Series A to help gamers monetize their data
• Dot Compliance (Israel) raises USD 17.5 million in Series B extension to promote AI-driven compliance
• Guesty (IL) Raises USD 130M to Accelerate Global Expansion
• Nucleai (Israel) raises USD14 million led by Merck’s VC arm
• Obsidian Therapeutics (HC) Secures USD 160.5M Series C Financing for Innovative Cell Therapy
• TORL BioTherapeutics (HC) Announces USD158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

• CARV (China) partners with Aethir To Power Next-Gen Gaming And AI, Offering Reciprocal Rewards Between Communities
• Geek+ (China & Growth) Collaborates with Toll Group to Launch its First Robotics Sorting Warehouse in Korea
• Hotelogix (US) partners with HostBooks to help hotels with streamlined accounting process
• Nucleai (Israel) and GoPath Diagnostics Announce Strategic Collaboration to Provide Integrated AI-powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications
• Nium (SEA, India & Growth) signs Partnership MOU with Indonesian Payments Infrastructure Leader, Artajasa
• Nium (SEA, India & Growth) and Thredd Launch APAC Virtual Card Partnership
• Nium (SEA, India & Growth) and Kapronasia Partner to Shed Light on Cross-border B2B Payment Challenges in Asia
• Nium (SEA, India & Growth) signs Partnership MOU with Indonesian Payments Infrastructure Leader, Artajasa
• Nium (SEA, India & Growth) and Trulioo Partner to Enhance UK Operations With Rapid, Compliant Payment Experiences

• Vectara (US) and Datavolo Partner to Accelerate Enterprise Retrieval Augmented Generation Application

• Boundless Bio (Healthcare) Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
• Hasura (US) debuts supergraph features to simplify complex API data integrations
• Nium (SEA, India & Growth) Appoints Banking Industry Expert, Alexandra Johnson, to Scale Global Banking and Payment Operations as Chief Payments Officer
• Obsidian Therapeutics (Healthcare) Appoints Jeffrey Trigilio as Chief Financial Officer
• Obsidian Therapeutics (Healthcare) Presents Positive 25-Week Median Study Follow-Up Safety and Efficacy Data from First-in-Human Study of OBX-115 in Advanced Melanoma at the American Association for Cancer Research Annual Meeting
• SpyGlass Pharma (Healthcare) Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma

• Geek+ (China & Growth) awarded RBR innovation award for third time, named among globe’s top robotics innovators
• RAD Security (US) Selected as Finalist for RSA Conference 2024 Innovation Sandbox Contest